Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood substitutes: how close to a solution?

H G Klein1

  • 1Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. hk29h@nih.gov

Developments in Biologicals
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen-reduction methods: advantages and limits.

ISBT science series·2020
Same author

Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis.

Transfusion medicine (Oxford, England)·2018
Same author

International Forum regarding practices related to donor haemoglobin and iron.

Vox sanguinis·2016
Same author

Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis.

Vox sanguinis·2016
Same author

Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

Vox sanguinis·2011
Same author

The relevance of practice misalignments to trials in transfusion medicine.

Vox sanguinis·2010

Red cell substitutes (RCS) are being developed to deliver oxygen, but their physiological effects are not fully understood. Early-generation RCS may serve specific roles in trauma and surgery, not chronic anemia.

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Pharmacology

Background:

  • The term "blood substitute" is often inaccurately used for "red cell substitute" (RCS).
  • Ideal RCS characteristics include oxygen delivery, no compatibility testing, minimal side effects, long storage, circulation persistence, and affordability.
  • Several early-generation RCS are nearing licensing for specific applications.

Purpose of the Study:

  • To review the development and potential applications of red cell substitutes.
  • To highlight the current understanding and challenges associated with RCS formulations.
  • To discuss the physiological consequences of oxygen delivery by small molecules in RCS.

Main Methods:

  • Review of current red cell substitute (RCS) development, including hemoglobin-derived and perfluorochemical-based options.

Related Experiment Videos

  • Analysis of the physical characteristics, biological activities, and adverse reaction profiles of different RCS formulations.
  • Examination of the physiological consequences of oxygen delivery by small molecules.

    • Main Results:

    • Haemoglobin-derived and perfluorochemical-based RCS are in various stages of development.
    • The physiological effects of oxygen delivery by small molecules in RCS are not well understood.
    • Current RCS in Phase III trials have short half-lives, limiting their use in chronic anemia.

    Conclusions:

    • Early-generation RCS are unlikely to replace transfusions or erythropoiesis-stimulating drugs for chronic anemia.
    • RCS may be valuable in emergency resuscitation for trauma, as a bridge to transfusion, in autologous blood management during surgery, and potentially in cancer therapy.
    • Further research is needed to fully understand the physiological consequences of RCS and optimize their therapeutic applications.